CroíValve Reports Successful First in Human Implants of its DUO Tricuspid Coaptation Valve System
Dublin, Ireland, 18 November 2022 - CroíValve has announced the successful First in Human implants...
Search for Articles
Nov 18, 2022
Oct 10, 2022
Renovacor Announces Upcoming Presentation at the 29th European Society of Gene & Cell Therapy Congress
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies...
Sep 27, 2022
Puzzle Medical Devices Inc. Wins TCT 2022 Shark Tank Innovation Competition
NEW YORK – September 27, 2022 – The Cardiovascular Research Foundation (CRF) is pleased to...
Sep 27, 2022
Renovacor Announces Upcoming Presentation at Keystone Symposia’s Heart Failure: Mechanisms and Therapies Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision...
Sep 20, 2022
Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy
CRANBURY, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage, clinical biotechnology...
Sep 19, 2022
First-in-Human Study Finds Mechanical Circulatory Support and Renal Perfusion Success with the ModulHeart Device
September 19, 2022 — A first-in-human (FIH) study using the ModulHeart device (Puzzle Medical Devices Inc.) has demonstrated...